Latest News

Automated computational protocol identifies potential SARS-CoV-2 MPro inhibitor




As scientists race to discover new and effective antiviral drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many novel approaches are being utilized. Now, a new study published on the preprint bioRxiv in September 2020 reports on the discovery of a potentially beneficial enzyme blocker that could inhibit SARS-CoV-2 viral replication.

Source link

Related posts

Aiming higher to bend the curve of biodiversity loss

Newsemia

Japanese Diet Health Benefits That Will Surprise You

Newsemia

Pinnacle Treatment Centers to Open Detox Wing at University Hospitals Portage Medical Center

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World